Parker Waichman LLP Headlines by Topic
Serevent
Warnings for Long-Acting Asthma Drugs Take Effect
Jun 3, 2010
| Parker Waichman LLP
New warnings for the inhaled asthma drugs Advair, Serevent, Foradil and Symbicort have been finalized by the U.S. Food & Drug Administration...
FDA Seeks to Limit Use of Serevent, Advair, Symbicort and Foradil
Feb 19, 2010
| Parker Waichman LLP
U.S. regulators want to limit the use of Serevent, Advair, Symbicort and Foradil. The four drugs, part of a class of asthma medications known...
FDA Panel Wants Restrictions on Two Asthma Drugs
Dec 12, 2008
| Parker Waichman LLP
A U.S. Food and Drug Administration (FDA) panel has called for restrictions on two asthma treatments: Serevent and Foradil. Both belong...
FDA Considers Heart Risks of Serevent, Foradil, Advair and Symbicort
Dec 11, 2008
| Parker Waichman LLP
One expert estimates that long-acting beta-agonists (LABAs) - a class of asthma drugs that includes Serevent, Foradil, Advair, and Symbicort -...
Complications, Deaths Seen with Some Long-Acting Asthma Drugs
Dec 5, 2008
| Parker Waichman LLP
Some asthma drugs in a class known as long-acting beta agonists (LABA) can increase the risk of death and complications, a new Food & Drug...
Asthma Med Serevent Linked to Serious Adverse Events, Death
Jul 18, 2008
| Parker Waichman LLP
Researchers have just revealed that patients with chronic asthma who take the asthma medication Serevent—also known generically as...
FDA Seeks Info on Serevent, Advair, Foradil As Part of Safety Review
Mar 6, 2008
| Parker Waichman LLP
Asthma drugs, including Serevent, Advair, Foradil, are the subject of a Food & Drug Administration (FDA) safety review. The FDA has...
Serevent Should Have Stronger Warnings About Fatal Side Effects in Children, FDA Panel Says
Nov 29, 2007
| Parker Waichman LLP
Serevent, a top selling asthma drug, needs stronger safety warnings, a Food & Drug Advisory (FDA) panel said yesterday. The FDA panel's...
Serevent and Advair May Cause Injury, Death in Children, FDA Report Says
Nov 26, 2007
| Parker Waichman LLP
Serevent and Advair, top-selling asthma drugs, will take center stage this week, when a Food & Drug Administration (FDA) panel meets to discuss...
Researchers Say "Killer" Asthma Inhalers Should Be Recalled
Jun 20, 2006
| Consumer Affairs
Researchers from Cornell and Stanford universities have concluded three common asthma inhalers containing the drugs salmeterol or formoterol may be...
